Annual Interest Expense
N/A
31 December 2023
Summary:
Akari Therapeutics annual interest expense is not available.AKTX Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Interest Expense
$69.00 K
+$18.00 K+35.29%
01 September 2024
Summary:
Akari Therapeutics quarterly interest expense is currently $69.00 thousand, with the most recent change of +$18.00 thousand (+35.29%) on 01 September 2024. Over the past year, it has increased by +$69.00 thousand (+100.00%). AKTX quarterly interest expense is now -97.74% below its all-time high of $3.05 million, reached on 30 September 2015.AKTX Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Interest Expense
$120.00 K
+$69.00 K+135.29%
01 September 2024
Summary:
Akari Therapeutics TTM interest expense is currently $120.00 thousand, with the most recent change of +$69.00 thousand (+135.29%) on 01 September 2024. Over the past year, it has increased by +$120.00 thousand (+100.00%). AKTX TTM interest expense is now -96.08% below its all-time high of $3.06 million, reached on 30 September 2015.AKTX TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AKTX Interest Expense Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +100.0% | +100.0% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
AKTX Interest Expense High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | at high | ||||
| 5 y | 5 years | at high | at high | ||||
| alltime | all time | -97.7% | +1250.0% | -96.1% |
Akari Therapeutics Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $69.00 K(+35.3%) | $120.00 K(+135.3%) |
| June 2024 | - | $51.00 K(>+9900.0%) | $51.00 K(>+9900.0%) |
| Sept 2023 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2023 | - | $0.00(-100.0%) | $0.00(-100.0%) |
| Dec 2015 | $3.05 M | -$6000.00(-100.2%) | $3.06 M(-0.1%) |
| Sept 2015 | - | $3.05 M(>+9900.0%) | $3.06 M(>+9900.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2015 | - | $2600.00(-43.5%) | $8000.00(+48.1%) |
| Mar 2015 | - | $4600.00(-319.0%) | $5400.00(+575.0%) |
| Dec 2014 | $5400.00(-97.3%) | -$2100.00(-172.4%) | $800.00(-72.4%) |
| Sept 2014 | - | $2900.00 | $2900.00 |
| Dec 2013 | $202.00 K(-77.5%) | - | - |
| Dec 2012 | $898.00 K | - | - |
FAQ
- What is the all time high annual interest expense for Akari Therapeutics?
- What is Akari Therapeutics quarterly interest expense?
- What is the all time high quarterly interest expense for Akari Therapeutics?
- What is Akari Therapeutics quarterly interest expense year-on-year change?
- What is Akari Therapeutics TTM interest expense?
- What is the all time high TTM interest expense for Akari Therapeutics?
- What is Akari Therapeutics TTM interest expense year-on-year change?
What is the all time high annual interest expense for Akari Therapeutics?
Akari Therapeutics all-time high annual interest expense is $3.05 M
What is Akari Therapeutics quarterly interest expense?
The current quarterly interest expense of AKTX is $69.00 K
What is the all time high quarterly interest expense for Akari Therapeutics?
Akari Therapeutics all-time high quarterly interest expense is $3.05 M
What is Akari Therapeutics quarterly interest expense year-on-year change?
Over the past year, AKTX quarterly interest expense has changed by +$69.00 K (+100.00%)
What is Akari Therapeutics TTM interest expense?
The current TTM interest expense of AKTX is $120.00 K
What is the all time high TTM interest expense for Akari Therapeutics?
Akari Therapeutics all-time high TTM interest expense is $3.06 M
What is Akari Therapeutics TTM interest expense year-on-year change?
Over the past year, AKTX TTM interest expense has changed by +$120.00 K (+100.00%)